Jean Marie Duvall

Jean Marie Duvall is an accomplished executive with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as a Board Member for Roquefort Therapeutics plc and Ondine Biomedical Inc., and as Co-Founder and CEO of ReproNovo, Jean Marie Duvall has played a pivotal role in reproductive medicine and women's health. From 2006 to 2021, Jean Marie Duvall was Executive Vice President at Ferring Pharmaceuticals, where strategic leadership in corporate development and legal affairs was demonstrated, alongside the establishment of compliance and ethics functions. As Co-Founder and Executive Chairman of Trizell Holding SA and Co-Chairman of FerGene, Jean Marie Duvall successfully advanced gene and cell therapy initiatives. Educational qualifications include a JD from The Ohio State University Moritz College of Law and a BS in Biomedical Engineering from Case Western Reserve University.